Quick Answer
TRINITY BIOTECH PLC reported Gross Profit of $21.44 million for fiscal year 2024.
TRINITY BIOTECH PLC Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2024 | $21.44M | +10.2% |
| 2023 | $19.45M | +12.6% |
| 2022 | $17.27M | -48.4% |
| 2021 | $33.45M | -31.1% |
| 2020 | $48.58M | +27.4% |
| 2019 | $38.12M | -8.0% |
| 2018 | $41.45M | -1.1% |
| 2017 | $41.89M | -3.7% |
| 2016 | $43.48M | -6.5% |
| 2015 | $46.51M | — |
- TRINITY BIOTECH PLC showed an increase of +10.2% in Gross Profit compared to the prior fiscal year.
- Over the 2015–2024 period, TRINITY BIOTECH PLC’s gross profit has declined by 53.9% (from $46.51 million to $21.44 million).
- The most recent figure is from TRINITY BIOTECH PLC’s fiscal year 2024 report (Form 20-F), filed with the SEC on May 16, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: